Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel plus trastuzumab (TH) (ATEMPT) trial (TBCRC 033)
Ann Partridge,Yue Zheng,Shoshana Rosenberg,Richard Gelber,Shari Gelber,William Barry,Chau Dang,Denise Yardley,Steven Isakoff,Vicente Valero,Meredith Faggen,Therese Mulvey,Ron Bose,Douglas Weckstein,Antonio Wolff,Katherine Reeder-Hayes,Hope Rugo,Bhuvaneswari Ramaswamy,Dan Zuckerman,Lowell Hart,Vijayakrishna Gadi,Michael Constantine,Kit Cheng,Frederick Briccetti,Bryan Schneider,Merrill Garrett,P. Kelly Marcom,Kathy Albain,Patricia Defusco,Nadine Tung,Blair Ardman,Rita Nanda,Rachel Jankowitz,Michelle Demeo,Harold Burstein,Eric P. Winer,Ian Krop,Sara Tolaney CANCER RESEARCH(2020)
AI 理解论文
溯源树
样例